Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: A case series

Journal of Bone and Joint Surgery - Series B

Volumn 93 B, Issue 5, 2011, Pages 695-699

  Spiro, A S ^a   Babin, K ^b   Lipovac, S ^b   Stenger, P ^b   Mladenov, K ^b   Rupprecht, M ^a   Rueger, J M ^a   Stuecker, R ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Altonaer Kinderkrankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL PSEUDARTHROSIS; FEMALE; FOLLOW UP; FRACTURE EXTERNAL FIXATION; HUMAN; ILIZAROV TECHNIQUE; INTRAMEDULLARY NAIL; MALE; MEDICAL RECORD; PRESCHOOL CHILD; PRIORITY JOURNAL; TIBIA;

ANKLE JOINT; BONE MORPHOGENETIC PROTEINS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EXTERNAL FIXATORS; FEMALE; FOLLOW-UP STUDIES; FRACTURE FIXATION, INTRAMEDULLARY; FRACTURE HEALING; HUMANS; ILIZAROV TECHNIQUE; KNEE JOINT; MALE; PSEUDARTHROSIS; RANGE OF MOTION, ARTICULAR; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TIBIAL FRACTURES; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955121732     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.93B5.25938     Document Type: Article

References (25)

1. Vander Have KL, Hensinger RN, Caird M, Johnston C, Farley FA. Congenital pseudarthrosis of the tibia. J Am Acad Orthop Surg 2008;16:228-36.
2. Traub JA, O'Connor W, Masso PD. Congenital pseudarthrosis of the tibia: a retrospective review. J Pediatr Orthop 1999;19:735-8.
3. Minami A, Kasahima T, Iwasaki N, Kato H, Kaneda K. Vascularised fibular grafts: an experience of 102 patients. J Bone Joint Surg [Br] 2000;82-B:1022-5.
4. Kim HW, Weinstein SL. Intramedullary fixation and bone grafting for congenital pseudarthrosis of the tibia. Clin Orthop 2002;405:250-7. (Pubitemid 36008269)
5. Guidera KJ, Raney EM, Ganey T, et al. Ilizarov treatment of congenital pseudarthroses of the tibia. J Pediatr Orthop 1997;17:668-74. (Pubitemid 28048755)
6. Joseph B, Somaraju VV, Shetty SK. Management of congenital pseudarthrosis of the tibia in children under 3 years of age: effect of early surgery on union of the pseudarthrosis and growth of the limb. J Pediatr Orthop 2003;23:740-6. (Pubitemid 37323060)
7. Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL. Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia: a long-term follow-up study. J Bone Joint Surg [Am] 2004;86-A:1186-97. (Pubitemid 38724881)
8. Inan M, El Rassi G, Riddle EC, Kumar SJ. Residual deformities following successful initial bone union in congenital pseudarthrosis of the tibia. J Pediatr Orthop 2006;26:393-9.
9. Ohnishi I, Sato W, Matsuyama J, et al. Treatment of congenital pseudarthrosis of the tibia: a multicenter study in Japan. J Pediatr Orthop 2005;25:219-24. (Pubitemid 40315442)
10. Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-62.
11. Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg [Am] 2001;83-A:803-16. (Pubitemid 32523799)
12. Kloen P, Di Paola M, Borens O, et al. BMP signaling components are expressed in human fracture callus. Bone 2003;33:362-71. (Pubitemid 37103253)
13. Spiro AS, Beil FT, Baranowsky A, et al. BMP-7 induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6-mice. J Orthop Res 2010;28:785-91.
14. Ripamonti U, Van Den Heever B, Sampath TK, et al. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 1996;13:273-89. (Pubitemid 26378946)
15. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions: a prospective, randomized clinical trial comparing rhOP-1 with fresh bone autograft. J Bone Joint Surg [Am] 2001;83-A(Suppl):151-8.
16. Govender S, Csimma C, Genant HK, et al; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 2002;84-A:2123-34. (Pubitemid 35417689)
17. Richards BS, Oetgen ME, Johnston CE. The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series. J Bone Joint Surg [Am] 2010;92-A:177-85.
18. Lee FY, Sinicropi SM, Lee FS, et al. Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7): a report of five cases. J Bone Joint Surg [Am] 2006;88-A:627-33.
19. Fabeck L, Ghafil D, Gerroudj M, Baillon R, Delincé P. Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg [Br] 2006;88-B:116-18. (Pubitemid 43125326)
20. Kujala S, Vähäsarja V, Serlo W, Jalovaara P. Treatment of congenital pseudarthrosis of the tibia with native bovine BMP: a case report. Acta Orthop Belg 2008;74:132-6.
21. Anticevic D, Jelic M, Vukicevic S. Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report. J Pediatr Orthop B 2006;15:220-1.
22. Crawford AH. Neurofibromatosis in the pediatric patient. Orthop Clin North Am 1978;9:11-23. (Pubitemid 8405490)
23. Grill F, Bollini G, Dungl P, et al. Treatment approaches for congenital pseudarthrosis of tibia: results of the EPOS multicenter study (European Paediatric Orthopaedic Society). J Pediatr Orthop B 2000;9:75-89. (Pubitemid 30253772)
24. Cho TJ, Choi IH, Lee SM, et al. Refracture after Ilizarov osteosynthesis in atrophic-type congenital pseudarthrosis of the tibia. J Bone Joint Surg [Br] 2008;90-B:488-93. (Pubitemid 351542868)
25. Oetgen ME, Richards BS. Complications associated with the use of bone morphogenetic protein in pediatric patients. J Pediatr Orthop 2010;30:192-8.